COMMUNIQUÉS West-GlobeNewswire

Nicox Establishes High-Profile Glaucoma Clinical Advisory Board
28/01/2019
Press Release Nicox Establishes High-Profile Glaucoma Clinical Advisory Board ............................................... Key U.S. clinical investigators and opinion leaders to support and guide the development of [...]
Nicox constitue un Comité consultatif clinique d'experts sur le glaucome
28/01/2019
Communiqué de presse Nicox constitue un Comité consultatif clinique d'experts sur le glaucome ................................................. Développement des thérapies donneuses d'oxyde nitrique innovantes de Nicox [...]
Biocartis Group NV: Disclosure of a transparency notification
28/01/2019
PRESS RELEASE : REGULATED INFORMATION 28 January 2019, 07:00 CET Disclosure of a transparency notification Mechelen, Belgium, 28 January 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
EDITORIAL ON POSITIVE DATA FOR BARHEMSYS™ RESCUE TREATMENT OF POST-OPERATIVE NAUSEA & VOMITING (PONV) PUBLISHED IN ANESTHESIOLOGY
28/01/2019
Cambridge, UK and Indianapolis, US – 28 January 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) welcomes an editorial published in the leading peer-reviewed journal Anesthesiology , [...]
Genmab Announces that the patents asserted against DARZALEX® in the United States have been declared invalid by summary judgment.
26/01/2019
Company Announcement Patents asserted against Janssen Biotech, Inc. & Genmab in the United States have been declared invalid by summary judgment Copenhagen, Denmark; January 26, 2019 – Genmab A/S (Nasdaq Copenhagen [...]
Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
25/01/2019
WARREN, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced the closing and funding of its [...]
New York Stock Exchange Accepts Milestone Scientific’s Plan to Regain Compliance
25/01/2019
LIVINGSTON, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
25/01/2019
BOTHELL, Wash., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Thursday, February 28, 2019
25/01/2019
MORRISVILLE, N.C., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
25/01/2019
RADNOR, Pa., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
N.M. Medical Cannabis Program Finishes 2018 With $106 Million in Sales
25/01/2019
Patients choose Ultra Health by 6 to 1; Industry hampered by regulatory hurdles ALBUQUERQUE, N.M., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Combined patient sales from the 35 licensed producers in New Mexico’s Medical Cannabis [...]
Dr. Amir Bajoghli has been chosen as president of the Medical Society of Northern Virginia
25/01/2019
MCLEAN, Va., Jan. 25, 2019 (GLOBE NEWSWIRE) -- One of the most prestigious medical organizations in the DC Metropolitan area, the Medical Society of Northern Virginia ( MSNVA ), is devoted to the advancement of medicine [...]
MacroGenics Announces Removal of Partial Clinical Hold on MGD009 Program by FDA
25/01/2019
ROCKVILLE, MD, Jan. 25, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
UPDATE: Tauriga Sciences Inc. Showcases its Graphic Design and Artwork for the Individual Pack of its CBD Infused Gum
25/01/2019
New York, NY, Jan. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgen’s Humira Biosimilar Formulation
25/01/2019
Complaint alleges Amgen infringes three U.S. patents recently awarded to Coherus REDWOOD CITY, Calif., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), a commercial biosimilar company, today [...]
First Patient in the World to Receive Breakthrough Robotic Spine Surgery by Virginia Spine Institute
25/01/2019
Spine Surgeons Dr. Christopher Good and Dr. Colin Haines utilize most advanced robotic guidance system to perform complex scoliosis correction surgery RESTON, Va., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Virginia Spine [...]
Organic & Natural Health to Ramp Up Omega-3 Nutrient Field Study Participant Numbers to 5,000
25/01/2019
WASHINGTON, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Just two years ago, Organic & Natural Health Association announced that omega-3 would be its new nutrient of focus for its “ Nutrient Power ” campaign to increase [...]
Aura Announces Binding LOI to Acquire Licenced Medical Cannabis Distributor in Germany
25/01/2019
TORONTO, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased to announce that the Company has entered into a binding letter of intent (the “LOI ”) to acquire 80% of [...]
Annulment of shares and amendment of the terms of option rights
25/01/2019
Company announcement, Helsinki, 25.1.2019 at 17:30 Annulment of shares and amendment of the terms of option rights The Extraordinary General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation [...]

Pages